Zentalis Pharmaceuticals, Inc.
ZNTL
Revenue
0.00
▼-40.56M▼-100.00%
3 Months ChangeAssets
491.68M
▼-65.80M▼-11.80%
3 Months ChangeLiabilities
109.10M
▲10.39M▲10.53%
3 Months ChangeFree Cash Flow
-52.01M
▼-2.73M▼-5.54%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 8-K
ID: 0001725160-24-000161
2024-08-09
Form 10-Q
ID: 0001725160-24-000158
2024-08-09
Form 8-K
ID: 0001725160-24-000157
2024-06-21
Form 8-K
ID: 0001725160-24-000140
2024-06-03
Form 8-K
ID: 0001725160-24-000131
2024-05-29
Form 8-K
ID: 0001725160-24-000120
2024-05-07
Form 10-Q
ID: 0001725160-24-000107
2024-05-07
Form 8-K
ID: 0001725160-24-000106
2024-04-11
Form 8-K
ID: 0001725160-24-000087
2024-04-09
Form 8-K
ID: 0001725160-24-000082